Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 103-112, June 2006

Fabrication of biofunctional nanomaterials via Escherichia coli OmpF protein air/water interface insertion/integration with copolymeric amphiphiles

  • Dean Ho, PhD

      Affiliations

    • Department of Mechanical and Aerospace Engineering, Henry Samueli School of Engineering and Applied Science, University of California at Los Angeles, Los Angeles, California
    • Corresponding Author InformationCorresponding author. Henry Samueli School of Engineering and Applied Science, University of California at Los Angeles, 7523 Boelter Hall, 420 Westwood Plaza, Los Angeles, California 90095.
  • ,
  • Stacy Chang, BS

      Affiliations

    • Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California at Los Angeles, Los Angeles, California
  • ,
  • Carlo D. Montemagno, PhD

      Affiliations

    • Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California at Los Angeles, Los Angeles, California

Received 23 September 2005; accepted 22 December 2005.

Abstract 

Fabrication of next-generation biologically active materials will involve the integration of proteins with synthetic membrane materials toward a wide spectrum of applications in nanoscale medicine, including high-throughput drug testing, energy conversion for powering medical devices, and bio-cloaking films for mimicry of cellular membrane surfaces toward the enhancement of implant biocompatibility. We have used ABA triblock copolymer membranes (PMOXA-PDMS-PMOXA) of varied thicknesses as platform materials for Langmuir film–based functionalization with the OmpF pore protein from Escherichia coli by fabricating monolayers of copolymer amphiphile-protein complexes on the air/water interface. Here we demonstrate that the ability for protein insertion at the air/water interface during device fabrication is dependent upon the initial surface coverage with the copolymer as well as copolymer thickness. Methacrylate-terminated block copolymer structures that were 4 nm (4METH) and 8 nm (8METH) in length were used as the protein reconstitution matrix, whereas a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) lipid (~4 nm thickness) was used as a comparison to demonstrate the effects of copolymer length on protein integration capabilities. Wilhemy surface pressure measurements (mN/m) revealed a greater protein insertion in the 4METH and POPC structures compared with the 8METH structure, indicating that shorter copolymer chains possess enhanced biomimicry of natural lipid-based membranes. In addition, comparisons between the isothermal characteristics of the 4METH, 8METH, and POPC membranes reveal that phase transitions of the 4METH resemble a blend of the 8METH and POPC materials, indicating that the 4METH chain may possess hybrid properties of both copolymers and lipids. Furthermore, we have shown that following the deposition of the amphiphilic materials on the air/water interface, the OmpF can be deposited directly on top of the amphiphiles (surface addition), thus effectively further enhancing protein insertion because of the buoying effects of the membranes. These characteristics of Langmuir-Blodgett–based fabrication of copolymer-biomolecule hybrids represent a synthesis strategy for next-generation biomedical materials.

Key words: Nanomaterials, Bio-cloaking, Protein, Copolymer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors gratefully thank the T. Schirmer group at the Division of Structural Biology, Biozentrum, University of Basel, Basel, Switzerland for the OmpF plasmid.

PII: S1549-9634(06)00009-8

doi:10.1016/j.nano.2005.12.004

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 2, Issue 2 , Pages 103-112, June 2006